ProfileGDS5068 / 230691_at
TitleRheumatoid arthritic synovium response to tocilizumab
OrganismHomo sapiens


baseline tocilizumab patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 GSM1116933 GSM1116935 GSM1116937 GSM1116939 GSM1116941 GSM1116943 GSM1116945 GSM1116947 GSM1116949 GSM1116951 GSM1116953 GSM1116955 GSM1116934 GSM1116936 GSM1116938 GSM1116940 GSM1116942 GSM1116944 GSM1116946 GSM1116948 GSM1116950 GSM1116952 GSM1116954 GSM1116956 16% 76% 56% 45% 49% 84% 71% 11% 63% 42% 77% 26% 33% 72% 27% 47% 25% 38% 54% 87% 41% 16% 39% 32% sort by agent sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1116933Synovial tissue prior to Tocilizumab therapy, repl 1-0.23743416
GSM1116935Synovial tissue prior to Tocilizumab therapy, repl 20.13432976
GSM1116937Synovial tissue prior to Tocilizumab therapy, repl 30.019616656
GSM1116939Synovial tissue prior to Tocilizumab therapy, repl 4-0.005502745
GSM1116941Synovial tissue prior to Tocilizumab therapy, repl 50.003153849
GSM1116943Synovial tissue prior to Tocilizumab therapy, repl 60.20052884
GSM1116945Synovial tissue prior to Tocilizumab therapy, repl 70.13743971
GSM1116947Synovial tissue prior to Tocilizumab therapy, repl 8-0.25101311
GSM1116949Synovial tissue prior to Tocilizumab therapy, repl 90.032611463
GSM1116951Synovial tissue prior to Tocilizumab therapy, repl 10-0.038315342
GSM1116953Synovial tissue prior to Tocilizumab therapy, repl 110.15409977
GSM1116955Synovial tissue prior to Tocilizumab therapy, repl 12-0.10527226
GSM1116934Synovial tissue after to Tocilizumab therapy, repl 1-0.14410533
GSM1116936Synovial tissue after to Tocilizumab therapy, repl 20.14166872
GSM1116938Synovial tissue after to Tocilizumab therapy, repl 3-0.091597627
GSM1116940Synovial tissue after to Tocilizumab therapy, repl 40.015049947
GSM1116942Synovial tissue after to Tocilizumab therapy, repl 5-0.13209525
GSM1116944Synovial tissue after to Tocilizumab therapy, repl 6-0.034491138
GSM1116946Synovial tissue after to Tocilizumab therapy, repl 70.0016703654
GSM1116948Synovial tissue after to Tocilizumab therapy, repl 80.25525687
GSM1116950Synovial tissue after to Tocilizumab therapy, repl 9-0.045566141
GSM1116952Synovial tissue after to Tocilizumab therapy, repl 10-0.17929216
GSM1116954Synovial tissue after to Tocilizumab therapy, repl 11-0.037473739
GSM1116956Synovial tissue after to Tocilizumab therapy, repl 12-0.073420532